Top Stories
-
By analyzing thousands of genetic risk variants, a new algorithm developed by Columbia researchers may be able to predict your risk of developing chronic kidney disease decades before onset.
Topic
-
To make genetic tests clinically useful for non-European groups, we must focus on efforts that take group concerns into account.
Topic
-
When you try to lose weight—and keep the weight off—you’re battling your body and your genes.
Topic
-
Using advanced imaging methods, researchers have gained insight into how a common target of drugs sends cellular signals, a finding that may lead to better and more precise therapeutics.
Latest News
- March 9, 2021
A clinical trial to test a gene therapy for some patients with dry age-related macular degeneration—a leading cause of blindness in the United States—is underway at Columbia and NewYork-Presbyterian.
Topic
- February 25, 2021
Spread of a new SARS-CoV-2 variant in the New York City region that shares worrisome similarities with other recent variants has been identified by scientists at Columbia University.
Topic
- February 24, 2021
By deploying CRISPR to make the smallest mutations, researchers are learning how subtle changes to genes contribute to disease.
Topic
- February 8, 2021
Cells used to study the human blood-brain barrier in the lab aren’t what they seem, a new study has found, throwing nearly a decade’s worth of research into question.
Topic
- February 8, 2021
In NIH funding for Federal Fiscal Year 2020, VP&S reached its highest ranking ever. Nursing and Mailman School of Public Health also ranked high.
Topic
- January 11, 2021
A new analysis of almost 10,000 patients found that tumors could be stratified into 112 subtypes regardless of the cancer’s origin.
Topic
- January 11, 2021
A new study has found that up to 20% of aggressive brain cancers are fueled by overactive mitochondria and new drugs in development may be able to starve the cancers.
Topic
- January 4, 2021
New images of Wnt, a signaling protein mutated in some cancers, in complex with its specific carrier, reveals atomic-level details of the molecules and a potential new drug target.
- December 23, 2020
A new study conducted at Columbia and other centers found that 80% of patients with a type of slow-growing lymphoma achieved a complete remission with a single infusion of CAR T-cell immunotherapy.
Topic
- December 22, 2020
In children with certain autism mutations, the diversity and severity of symptoms are often related to the identity and properties of gene units, called exons, targeted by the mutations.
Topic
